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Background: Individuals with human immunodeficiency virus (HIV) have an increased risk of developing
health problems, including some that are life threatening. Today, dental treatment for the population with
a positive HIV diagnosis (HIV+) is comprehensive. There are limited reports on the outcomes of intraoral sur-
gical therapy in patients with HIV, such as crown lengthening surgery (CLS) with osseous recontouring. This
report investigates the outcome of CLS procedures performed at an urban dental school in a population of
individuals with HIV. Specifically, this retrospective clinical analysis evaluates the healing response after
CLS.
Methods: Paper and electronic records were examined from the year 2000 to the present. Twenty-one in-
dividuals with HIV and immunosuppression, ranging from insignificant to severe, underwent CLS. Pertinent
details, including laboratory values, medications, smoking history/status, and postoperative outcomes,
were recorded. One such surgery is described in detail with radiographs, photographs, and a videoclip.
Results: Of the 21 patients with HIV examined after CLS, none had postoperative complications, such as
delayed healing, infection, or prolonged bleeding. Variations in viral load (<48 to 40,000 copies/mL), CD4 cell
count (126 to 1,260 cells/mm3), smoking (6 of 21 patients), platelets (130,000 to 369,000 cells/mm3), and
neutrophils (1.1 to 4.5 · 103 /mm3) did not impact surgical healing. In addition, variations in medication reg-
imens (highly active anti-retroviral therapy [18]; on protease inhibitors [1]; no medications [2]) did not have an
impact.
Conclusions: The results of this retrospective analysis show the absence of postoperative complica-
tions after CLS in this population with HIV. Additional investigation into this area will help health care
practitioners increase the range of surgical services provided to this group of patients. J Periodontol
2012;83:344-353.
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T
he introduction of highly active antiretroviral
therapy (HAART) has lead to reduction in the
incidence of new acquired immune deficiency
syndrome (AIDS) cases and the morbidity and mor-
tality associated with human immunodeficiency virus
infection (HIV).1-3 In the initial stages of the HIV epi-
demic, dental treatment was focused on the manage-
ment of HIV-associated oral lesions. Based on a survey
of dental professionals’ attitudes toward the treatment
of the population with HIV, some suggested that this
population required treatment in specialized centers.4
Other investigators have suspected this population to
have higher complication rates after dental procedures
but found no significant difference among individuals
with HIV+ and HIV-negative status (HIV-).5
Today, the population with HIV has the potential
for an increased life expectancy as a result of advances
in their overall care. Routine comprehensive care is of-
ten the primary dental need for well-managed patients
with HIV. This treatment may include preprosthetic
surgery, such as vestibuloplasty, soft-tissue grafting,
implant placement, implant-related procedures, and
crown lengthening (CLS).
According to a practice profile survey in2003, CLS is
one of the most common reasons for periodontal sur-
gery.6 Restoring teeth to their proper anatomic form,
function, and esthetics requires preparing a well-de-
fined restorative margin. For example, this may not
be obtainable in the presence of subgingival decay,
crown/root fracture, or endodontic perforation. CLS
makes the margins easily accessible for accurate im-
pressions and ultimately results in good marginal
adaptation of the restoration. In addition, CLS can
achieve longer clinical crowns7-11 and reestablish
the biologic width12,13 by removal of hard and soft tis-
sues.14-16 The general consensus is that CLS should
create ‡3 mm of sound tooth structure between the
alveolar crest and the restorative margin.17-19 There-
fore, surgical intervention in the form of CLS is often
necessary.20
Reports of intraoral surgical procedures in a popula-
tion with HIV are mainly limited to extractions,21-24 im-
plant placement,25-32 and vestibuloplasty using palatal
soft-tissue grafts.33 There are isolated reports of other
periodontal surgical procedures, including the use of
a lateral sliding flap and resin-modified glass ionomer
for the management of an isolated recession defect.34
To our knowledge, this is the first documentation that
describes CLS with osseous recontouring in a popula-
tion with HIV. In this retrospective analysis, only one
individual had a CD4 count of <200 cells/mm3. The re-
maining 20 patients had immunosuppression levels
that were generally mild (<500 cells/mm3 in eight pa-
tients) to no significant immunodeficiency (>500 cells/
mm3 in 12 patients).35
MATERIALS AND METHODS
An 11-year retrospective analysis of paper and elec-
tronic records (Institutional Review Board #0910-23)
at the University of Detroit Mercy School of Dentistry
(UDMSOD), Detroit, MI, was conducted, and 21 indi-
viduals with HIV were identified who underwent CLS.
The HIV+ status of patients is based on self-reporting
in the health history questionnaire and from the infor-
mation provided by their treating physicians. Presurgi-
cal laboratory values for each patient consisted of the
following: 1) CD4 cell count; 2) total white blood cell
count (WBC); 3) viral load; 4) neutrophil, platelet
count, hemoglobin, and hematocrit values. Other per-
tinent details, including medical history, medications,
smoking status, and postoperative (PO) outcomes,
were recorded. None of the patients required antibiotic
prophylaxis, and none were prescribed antibiotics
postoperatively.
All procedures were performed by periodontal fac-
ulty and periodontal residents at the UDMSOD under
local anesthesia.§ PO management included written
and verbal PO instructions and prescriptions for ibu-
profen (600 or 800 mg; every 6 to 8 hours as needed
for pain) and 0.12% chlorhexidine gluconate mouth
rinse (15 mL; twice daily). All patients were seen at
1, 2, and 4 weeks PO for clinical evaluation.
Different factors were analyzed and compared rel-
ative to the surgical outcome. For example, maxillary
versus mandibular, anterior versus posterior surgical
site, males versus females, smoking status, duration
of HIV+ status, and faculty versus resident performing
the procedure were compared.
A detailed description of the presurgical prepara-
tion, surgical procedure, and PO healing of one case
(#17) is provided below. The other CLS were per-
formed in a similar manner with minor changes made
to the flap design and amount of the bone removal
necessary based on the clinical situation. A summary
of all 21 cases can be found in Table 1.
Detailed Description of the Procedure Performed
in Case #17
A 62-year-old African American man was referred
to the Graduate Periodontics Clinic at the UDMSOD.
Recurrent subgingival decay was noted on the dis-
tal surfaces of both the first and second maxillary
right premolars (Fig. 1). After caries removal and
reevaluation, invasion of the biologic width was ob-
served on teeth #4 and #5, and CLS was conse-
quently indicated.
A review of the patient’s medical history indicated
that he was diagnosed with HIV in 1987 and has since
been regularly monitored by his physician. His medi-
cal history stated that he was positive for hepatitis B,
§ 2% lidocaine HCL with 1:100,000 epinephrine, Benco Dental, Wilkes-
Barre, PA.
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sickle cell trait, and has an allergy to latex and nickel.
He also had a history of cocaine use and smoking. The
patient’s current medications included the protease
inhibitors (lopinavir/ritonavir), an H2 receptor blocker
(ranitidine), and an H1 receptor blocker (cetirizine). A
review of the patient’s social history indicated married
status. He had been an active patient at UDMSOD
since 1975 and denied any significant changes in diet
during the past 5 years.
A presurgical medical consultation was sent to the
patient’s physician. The reported values are pre-
sented in Table 2.
Surgical Procedure
Written and oral informed consent for the surgical pro-
cedure was obtained, and the patient was educated
regarding the surgical procedure and the PO healing
and care. Profound anesthesia was obtained,§ and in-
trasulcular incisions were made on the facial and pal-
atal surfaces of teeth #3 to #6. Extrasulcular incisions
were made on the palatal surface of teeth #4 and #5
(Figs. 2A and 2B) (see supplementary video in the on-
line Journal of Periodontology). A full-thickness flap
was reflected facially and palatally. Ostectomy and
osteoplasty were completed using hand and rotary in-
struments under copious irrigation. The presence of
a bifurcation on the facial aspect of tooth #5 was noted
and care was taken to minimize bone removal in the
furcation area (Fig. 2C). The final topography of bone
represented positive architecture with a knife-edged
alveolar crest and the smooth transition of the bone
level between adjacent teeth. A periodontal probe
was used to confirm the presence of ‡3 mm of sound
tooth structure coronal to the crest of bone on both
premolars (Fig. 2D). The facial flap was apically po-
sitioned, and both flaps were sutured using 4-0 silk
suturesi (Figs. 2E and 2F). The provisional crowns
were cemented on both premolars using temporary
cement,¶ and a periodontal dressing# was placed over
the surgical site. The patient was advised to take ibu-
profen (600 mg as needed) and prescribed chlorhex-
idine gluconate rinse** (0.12%; twice daily for 2
weeks). The patient was asked to refrain from brush-
ing the surgical area and chewing on the right side and
was seen for PO appointments at 1, 3, and 4 weeks.
PO Healing Pattern
At the 1-week PO visit, the dressing and all remaining
sutures were removed. The surgical site appeared to
be healing well and the patient reported no post-sur-
gical concerns. He was asked to clean the surgical
area using an extra soft surgical toothbrush.†† The pa-
tient was then seen at 3 weeks PO, and the presence of
slight erythema on the palatal gingiva was observed in
the region of the premolars. Oral hygiene instructions
were reinforced. The patient was seen again at 4
weeks PO and uneventful healing was observed
(Fig. 3A). Approximately 12 weeks post-surgery,
porcelain-fused-to-metal crowns were cemented on
both premolars (Figs. 3B and 3C). For the next 2
years, the patient was seen regularly for routine dental
care. At the 2-year follow-up, the patient exhibited
pink healthy gingiva on teeth #4 and #5 with no visible
signs of inflammation, bleeding on probing, or plaque
accumulation. The gingival contour was firm and
knife-edged (Fig. 4A). The bitewing and periapical ra-
diograph revealed no evidence of recurrent caries,
Figure 1.
Preoperative radiograph showing recurrent subgingival decay (black
arrows) on the distal surfaces of both the first and second maxillary right
premolars.
Table 2.
Presurgical Laboratory Values for Case #17
Variables Values
CD4+ T lymphocyte count 800 cells/mm3
Viral load 115 copies/mL
Neutrophil count 4.2 · 103/mm3
WBC 7.9 · 103/mm3
Platelet count 162 · 103 cells/mm3
Hemoglobin 12.9 g/dL
Hematocrit 40.1%
i 4-0 silk suture, Ethicon, Somerville, NJ.
¶ Temp-Bond NE (Non-Eugenol) Accelerator, Kerr, Orange, CA.
# COE-PAK, GC America, Alsip, IL.
** 0.12% chlorhexidine gluconate, 3M ESPE, St. Paul, MN.
†† GUM, Sunstar Americas, Chicago, IL.
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marginal discrepancies, or periapical pathologies on
teeth #4 and #5 (Figs. 4B and 4C).
RESULTS
The evaluation of the data from the 21 cases shows
no complications with regard to delayed healing, pro-
longed bleeding, or infections. Most patients were
seen at 1, 2, and 4 weeks PO, and almost all were
treated by residents (19 of 21). The teeth were pre-
dominantly posterior teeth (19 of 21), with an equal
distribution between the two arches (10 CLS teeth
were in the mandible and 11 in the maxilla).
Figure 2.
A) Intrasulcular incision on the facial surfaces of teeth #3 to #6. B) Extrasulcular incisions were made on the palatal surface of teeth #3 and #6. C) The
presence of a bifurcation (black arrow) on the facial aspect of #5 was observed after flap reflection. D) The presence of ‡3 mm of sound tooth structure
on both premolars was confirmed. E) Facial view of apically positioned flap. F) Palatal view after sutures were placed.
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Figure 3.
A) Good oral hygiene seen around provisional crowns at the 4-week PO
visit. B) Healthy gingiva with an absence of plaque and inflammation
seen before cementation of definitive crowns. C) Facial view of definitive
crowns cemented 12 weeks after CLS.
Figure 4.
A) Two-year PO facial view. B) Two-year bitewing radiograph showing no
recurrent carious lesions. C) Two-year periapical radiograph showing
showing maintenance of biologic width and crestal bone level.
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The patients were predominantly male (17 of 21).
At the time of surgery, the duration of HIV+ diagnosis
ranged from 1 to 21 years (five were diagnosed in the
1980s, six in the 1990s, and 10 in the 2000s). Most of
the patients were non-smokers (15 of 21), five were
light smokers, and one was a heavy smoker. Despite
the effect of smoking on periodontal wound healing,
smoking did not appear to have an effect in the cases
presented here.36-38
It is also important to note that the variations in viral
load (<48 to40,000copies/mL),CD4cell count (126 to
1,260 cells/mm3), platelets (130,000 to 369,000 cells/
mm3), and neutrophils (1.1 to 4.5 · 103/mm3) did not
impact surgical healing. Based on CD4 counts, the
levels of immunosuppression were insignificant in 12
individuals (>500 cells/mm3), mild in five individuals
(350 to 499 cells/mm3), advanced in three individuals
(200 to 349 cells/mm3), and severe in one individ-
ual (<200 cells/mm3).35 Of the 21 patients, 18 were
on HAART, one only on protease inhibitors, and two
were taking no medications for HIV at the time of sur-
gery. This variation in medication regimens also did
not appear to have an impact on wound healing.
DISCUSSION
Oral manifestations are a classic component of the
AIDS epidemic.1 The discovery of HAART has brought
substantial benefits to the population with HIV, such as
improvements in their quality of life, increased life ex-
pectancy, and a dramatic decrease in oral manifesta-
tions of the disease.1-3 Today, the dental needs of
patients with HIV areconsistentwith the comprehensive
dental care needs seen in the general population. Al-
though antiretroviral medications are a mainstay in
the management of HIV, they may have some adverse
effects on the oral environment. A study that looked at
long-term antiretroviral medication use found a reduc-
tion in salivary flow that may indirectly contribute to
increased caries risk.39,40 The need for CLS in the pres-
ence of recurrent subgingival decay was described in
Case 17.
HIV infection does not appear to be a risk factor for
tooth loss according to a retrospective cross-sectional
study that involved 193 HIV+ patients and 192 system-
ically healthy patients.24 Using matched controls, com-
paring individuals with HIV+ to HIV- status, the results
showed that age, race, and smoking status were all risk
factors for tooth loss, but CD4+ cell count and viral load
in the HIV+ patients did not influence tooth loss. The au-
thors concluded that individuals with HIV treated with
HAART are not at an increased risk for tooth loss when
compared to systemically healthy individuals. Based
onthe fact that individualswithHIVareenjoyinga longer
lifespan and retaining their dentition for longer periods
of time, we can expect this population to need treat-
ment such as vestibuloplasty, soft-tissue grafting,
implant placement, implant-related procedures, and
CLS. This case series may be beneficial because it
is describing a similar procedure (CLS) in a large
group of individuals with HIV.
Most studies and clinical experience show that all
patients, including healthy individuals, are susceptible
to post-treatment complications when undergoing sur-
gical dental care. Comparisons of surgical complica-
tions between populations with HIV+ and HIV- status
are scarce. Glick5 conducted a retrospective study
on331 patients withHIV,with suppressed immunesys-
tems (CD4 counts of <200 cells/mm3). These patients
underwent 1,810 common invasive dental procedures,
including periodontal, restorative, endodontic, pros-
thodontic, and surgical procedures. These procedures
were performedby general dentists and had a low over-
all complication rate of only 0.9%. When we examined
the complication rate after surgical tooth extractions,
we found it to be similar for individuals with both HIV+
and HIV- status.5 Campo et al. evaluated post-treat-
ment complications in 101 patients with HIV. The over-
all complication rate in these patients was found to be
2.2% and 4.8% after invasive dental procedures. No
relationship was found among complications and
virologic, immunologic, or other laboratory values.21
In another study, a similar percentage (3.7% versus
2.9%) of postextraction complications is seen in pa-
tients with both HIV+ and HIV- status.16 A prospective
study by Dodson22 reported no differences in the com-
plication rates between patients with HIV+ and HIV-
status who underwent tooth extraction. Similarly, in
our study, therewerenocomplicationsnoted inpatients
with HIV whose viral loads varied from non-detectable
to 40,000 copies/mL. In our patient population, immu-
nosuppression levels ranged from insignificant to se-
vere and did not impact the PO wound healing. The
experience of the operator did not appear to have any
impact because the majority of the CLS in our series
were performed by residents.
A PO complication that has been studied is the oc-
currenceof infection in thesurgical area.Oneof thema-
jor reasons why invasive dental procedures are not
attempted on individuals with HIV is the presumption
that they are more susceptible to infections and compli-
cations after such procedures.23 Occasional reports
have suggested that the patients with HIV may present
a higher risk for PO infections after maxillofacial trauma
surgery compared to individuals with HIV- status. A
study41 showed that in thecaseofmandibular fractures,
preoperative infection rates were statistically significant
(26.4% versus6.5% for HIV+ versus HIV-). Although PO
infections were higher in cases with HIV+ than cases with
HIV- status, this difference was not statistically significant.
Most of the above cited authors agree that the rate of
complications inpatientswithHIV is similar inall stages
of the disease, including those with CD4+ lymphocyte
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counts of <200 cells/mm3. One of the cases presented
here had a CD4+ count of 126 cells/mm3, but it did not
seem to influence the outcome of CLS.
Dental surgical procedures, such as CLS, which in-
volves manipulation of periodontal tissues, is com-
monly associated with transient bacteremias. It is not
standard protocol to administer prophylactic antibi-
otics to prevent septicemia from bacteremias arising
from invasive dental procedures based solely on the
patient’s HIV status; however, antibiotic prophylaxis
is indicated for severely neutropenic patients with ab-
solute neutrophil counts that are <500 cells/mm3. A
systematic review by Patton et al.15 also concluded
that HIV status alone is not an indication for the routine
use of antibioticprophylaxisbefore dental treatment. In
the five studies that were reviewed, it was found that PO
complications in the patients with HIV were minor, and
treatment was done on an outpatient basis. Further-
more, none of the five studies suggested the necessity
for special precautions, such as administration of anti-
biotic prophylaxis based solely on the patient’s HIV sta-
tus. Based on the available evidence, no preoperative
antibiotics were prescribed in the casespresented here.
CONCLUSIONS
Currently available treatment for the population with
HIV/AIDS and a longer life expectancy has resulted in
the need for more comprehensive dental treatment of
patients with HIV. These procedures include prepros-
thetic, orthodontic, and periodontal surgical proce-
dures. The evaluation of the data from the 21 cases
presented here showed that there were no complica-
tions with regard to delayed healing, prolonged bleed-
ing, or infections after CLS in this population with HIV.
Smoking status did not have an impact on the occur-
rence of the complications, although 25% (six of 21)
of the patients were light smokers. We anticipate that
this case series will help demonstrate that a commonly
performed periodontal surgical procedure, such as
CLS, is safe and predictable in the population with HIV.
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